IBDEI0HY ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8306,1,4,0)
 ;;=4^D35.2
 ;;^UTILITY(U,$J,358.3,8306,2)
 ;;=^5002145
 ;;^UTILITY(U,$J,358.3,8307,0)
 ;;=D35.3^^35^442^8
 ;;^UTILITY(U,$J,358.3,8307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8307,1,3,0)
 ;;=3^Benign Neop of Craniopharyngeal Duct
 ;;^UTILITY(U,$J,358.3,8307,1,4,0)
 ;;=4^D35.3
 ;;^UTILITY(U,$J,358.3,8307,2)
 ;;=^5002146
 ;;^UTILITY(U,$J,358.3,8308,0)
 ;;=E21.0^^35^442^43
 ;;^UTILITY(U,$J,358.3,8308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8308,1,3,0)
 ;;=3^Hyperparathyroidism,Primary
 ;;^UTILITY(U,$J,358.3,8308,1,4,0)
 ;;=4^E21.0
 ;;^UTILITY(U,$J,358.3,8308,2)
 ;;=^331439
 ;;^UTILITY(U,$J,358.3,8309,0)
 ;;=I10.^^35^442^46
 ;;^UTILITY(U,$J,358.3,8309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8309,1,3,0)
 ;;=3^Hypertension,Essential
 ;;^UTILITY(U,$J,358.3,8309,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,8309,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,8310,0)
 ;;=E83.52^^35^442^40
 ;;^UTILITY(U,$J,358.3,8310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8310,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,8310,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,8310,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,8311,0)
 ;;=E23.0^^35^442^51
 ;;^UTILITY(U,$J,358.3,8311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8311,1,3,0)
 ;;=3^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,8311,1,4,0)
 ;;=4^E23.0
 ;;^UTILITY(U,$J,358.3,8311,2)
 ;;=^60685
 ;;^UTILITY(U,$J,358.3,8312,0)
 ;;=E55.9^^35^442^86
 ;;^UTILITY(U,$J,358.3,8312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8312,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,8312,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,8312,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,8313,0)
 ;;=E26.9^^35^442^39
 ;;^UTILITY(U,$J,358.3,8313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8313,1,3,0)
 ;;=3^Hyperaldosteronism,Unspec
 ;;^UTILITY(U,$J,358.3,8313,1,4,0)
 ;;=4^E26.9
 ;;^UTILITY(U,$J,358.3,8313,2)
 ;;=^5002738
 ;;^UTILITY(U,$J,358.3,8314,0)
 ;;=E27.49^^35^442^3
 ;;^UTILITY(U,$J,358.3,8314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8314,1,3,0)
 ;;=3^Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,8314,1,4,0)
 ;;=4^E27.49
 ;;^UTILITY(U,$J,358.3,8314,2)
 ;;=^5002743
 ;;^UTILITY(U,$J,358.3,8315,0)
 ;;=E16.2^^35^442^48
 ;;^UTILITY(U,$J,358.3,8315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8315,1,3,0)
 ;;=3^Hypoglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,8315,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,8315,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,8316,0)
 ;;=F64.1^^35^442^34
 ;;^UTILITY(U,$J,358.3,8316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8316,1,3,0)
 ;;=3^Gender Identity Disorder
 ;;^UTILITY(U,$J,358.3,8316,1,4,0)
 ;;=4^F64.1
 ;;^UTILITY(U,$J,358.3,8316,2)
 ;;=^5003647
 ;;^UTILITY(U,$J,358.3,8317,0)
 ;;=E28.39^^35^442^49
 ;;^UTILITY(U,$J,358.3,8317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8317,1,3,0)
 ;;=3^Hypogonadism,Female
 ;;^UTILITY(U,$J,358.3,8317,1,4,0)
 ;;=4^E28.39
 ;;^UTILITY(U,$J,358.3,8317,2)
 ;;=^5002752
 ;;^UTILITY(U,$J,358.3,8318,0)
 ;;=O92.6^^35^442^33
 ;;^UTILITY(U,$J,358.3,8318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8318,1,3,0)
 ;;=3^Galactorrhea
 ;;^UTILITY(U,$J,358.3,8318,1,4,0)
 ;;=4^O92.6
 ;;^UTILITY(U,$J,358.3,8318,2)
 ;;=^48842
 ;;^UTILITY(U,$J,358.3,8319,0)
 ;;=E22.1^^35^442^45
 ;;^UTILITY(U,$J,358.3,8319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8319,1,3,0)
 ;;=3^Hyperprolactinemia
 ;;^UTILITY(U,$J,358.3,8319,1,4,0)
 ;;=4^E22.1
 ;;^UTILITY(U,$J,358.3,8319,2)
 ;;=^60265
 ;;^UTILITY(U,$J,358.3,8320,0)
 ;;=N62.^^35^442^37
 ;;^UTILITY(U,$J,358.3,8320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8320,1,3,0)
 ;;=3^Gynecomastia
